on 16 Feb 2024
Last Applicant/ Owned by
CH-4600 Olten
CH
Serial Number
79190409 filed on 28th Apr 2016
Registration Number
5253131 registered on 01st Aug 2017
Filing Basis
1. filing basis filed as 66 a
Disclaimer
"MEDICAL"
Scientific and technological services and research and design relating thereto, namely, consumer product safety testing in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy equipment, scientific research in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy, design of diabetes, growth hormone deficiency, pain therapy, and chemotherapy moRead More
Medical services, in particular in the field of care for diabetics; medical testing and analysis for diagnostic or treatment purposes in the fields of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; medical diagnosis of diseases, in particular diabetic diseases; pharmacy advice, namely, pharmaceutical advice; medical and pharmaceutical consultancy, particularly in the field of diabetes; medical equipment rental in the fields of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; medical information, medical advice and medical consultancy, particularly relating to the treatment and care of diabetes; provision of educational information on diabetes via a website; provision of information on the use of medical diagnostic diabetes testing apparatus and consultancy in the field of medical diagnostics via a website
Scientific and technological services and research and design relating thereto, namely, consumer product safety testing in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy equipment, scientific research in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy, design of diabetes, growth hormone deficiency, pain therapy, and chemotherapy monitoring equipment for others; scientific and technological services and research and design relating thereto, namely, scientific research and new product design services in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; technological advice in the field of design and development of technology for devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; scientific laboratory services; scientific services, namely, conducting of clinical trials for others in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; conducting of clinical trials for others in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps, all in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; industrial analysis and research services in the field of design of medical equipment for use in the management and treatment of diabetes, growth hormone deficiency, pain therapy, and chemotherapy related medical equipment; industrial analysis and research services in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; bacteriological research services; biological research services; design and development of products in the field of fluids, mechanics, electronics and software; technical project study, namely, conducting scientific feasibility studies; research and development of new products for others; technical research services, namely, research in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy monitoring technology; carrying out scientific feasibility studies; testing of materials; measuring services, namely, calibration; quality control for others; design and development of software; installation, maintenance and updating and rental of software; software consultancy; all of the foregoing services relating to the fields of diabetes, growth hormone deficiency, pain therapy, and chemotherapy
Medical apparatus and instruments, namely, blood glucose meters, devices for measuring glycerin; medical apparatus for analyzing blood and blood plasma; medical apparatus for extracting and analyzing blood; apparatus for diagnoses and for analyses for medical use, in particular glucose meters, devices for measuring blood sugar; medical apparatus for introducing pharmaceutical preparations into the human body, in particular apparatus for introducing insulin and/or glucagon, namely, medical syringes, insulin injectors sold empty, and insulin and glycogen pumps; pumps for medical use, in particular mobile and portable insulin pumps and insulin patch pumps; insulin pumps, diuretic pumps and antibiotic pumps, all for medical use; belts for medical use; injectors for medical use, namely, medical fluid injectors; pens for injecting insulin and glucagon sold empty; brush pens and dispensation devices in the form of pens, sold empty, for accurate, precise dosing and application of medical creams and preparations; medical test kits for diabetes control for clinical or household use
No 79190409
No Service Mark
No 468.15(US)
No
No
No
No
Yes
Yes
No
No
26.09.21 -
Squares that are completely or partially shaded
The mark consists of the word "SENSILE" in gray above the word "MEDICAL" in blue. To the left these words is a stylized white letter "S" inside a blue square with two rounded corners.
| Status Date | Action Taken |
|---|---|
| 16th Feb 2024 | CANCELLED SECTION 71 |
| 01st Oct 2022 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 01st Aug 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 01st Dec 2017 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 13th Nov 2017 | FINAL DISPOSITION PROCESSED |
| 13th Nov 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
| 01st Nov 2017 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 26th Oct 2017 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 01st Aug 2017 | REGISTERED-PRINCIPAL REGISTER |
| 16th May 2017 | PUBLISHED FOR OPPOSITION |
